Special Report: The birth of biotechnology

  title={Special Report: The birth of biotechnology},
  author={Eugene Russo},
  • E. Russo
  • Published 23 January 2003
  • Engineering
  • Nature

Investor Reactions to New Product Development Failure in the Biotechnology Industry

This dissertation investigates important and cutting-edge issues surrounding new product development failure and its consequences for market values of innovation-driven firms. Although a substantial

Exploring Strategies to Integrate Disparate Bioinformatics Datasets

Exploring Strategies to Integrate Disparate Bioinformatics Datasets by

Long-term label-free assessments of individual bacteria using three-dimensional quantitative phase imaging and hydrogel-based immobilization

A protocol that utilizes hydrogels for high-quality 3D QPI of live bacteria maintaining bacterial physiology, including measuring the biophysical parameters of bacteria and responses to antibiotic treatments is introduced.

Cloning and Gene Manipulation

Anaerobic Fungal Mevalonate Pathway Genomic Biases Lead to Heterologous Toxicity Underpredicted by Codon Adaptation Indices

The bioproduction potential of anaerobic fungal enzyme homologs and how the analysis of codon utilization enables the study of otherwise difficult to express genes that have applications in biocatalysis and natural product discovery are demonstrated.

Fluctuations in the Global Food Market: Politics Versus Economics?

The current state of the global food system is characterized by a rapid increase in the concentration of capital at each stage of the production and distribution chain of the agricultural sector of

A Strategy for Advancing Research and Impact in New Computing Paradigms

This work states that several new computing paradigms, technologies and potential highimpact applications scenarios are emerging and present huge opportunities for researchers and practitioners in IT.

The Limitless Future of RNA Therapeutics

An overview of the RNA-based therapies that are currently being evaluated in clinical trials or have already received regulatory approval is provided, and a new concept of hospital-based RNA therapeutics is introduced and shared with the experience with establishing such a platform at Houston Methodist Hospital.

Escherichia coli as Model Organism and its Application in Biotechnology: A Review

In conclusion, E. coli are a natural mammalian gut bacteria used as a model organism for scientific research and is the most preferred microorganism to express heterologous proteins for therapeutic use.